With flu seasons now lasting longer, early and accurate diagnosis is crucial to identifying and rapidly treating infections. "Mobile enabled diagnostics will have a key role to play in combatting influenza outbreaks" says Neil Polwart, Novarum founder and BBI Group Head of Mobile.
With Infectious Diseases Flourishing – Could Mobile Enabled Diagnostics Offer New Hope In The Battle For Global Health?
With waves of major outbreaks of infectious diseases being unleashed on communities across the globe, finding new and improved solutions to tackle these fast-spreading diseases is becoming ever-more critical.
An outbreak of equine flu shutdown the UK horse racing industry recently, as veterinarians struggled to perform large volumes of nasal swab tests, and expedite samples to laboratories, preventing further postponement of high profile races. The industry, which is estimated to be worth £3.5bn to the UK economy¹, supports tertiary sectors such as transportation, catering, the media and gambling – all of which experienced financial loss in the past week.
Lateral flow assays (LFAs) are the mainstay of rapid point of care (POC) diagnostics, with the potential to enable early case management and transform the epidemiology of infectious disease. However, there are recognised limits in terms of sensitivity and specificity when compared to tests performed in a central laboratory.
Mobile technology is touching all our lives and it’s almost inevitable that at some stage your organisation will consider developing a mobile application to tap into this emerging market. Read our blog to understand the key considerations for understanding if mobile technology is the right solution.